Sample size (N=1479) and generalizability are the most limiting factors of this analysis as they are limited to the data collected during the SUSTAIN 6 trial and are focused only on patients who were taking Ozempic injection
GLP-1 receptor agonists not only reduce appetite but also reshape food preferences, shedding light on the neural mechanisms underlying compulsive consumption and offering potential therapeutic avenues for metabolic and behavioral disorders
longum A 2025 randomized, double-blind, placebo-controlled trial reported that a Bifidobacterium breve strain significantly raised GLP-1 and fecal butyrate while improving insulin resistance in adults with obesity
This article aims to help you make a measured, evidence oriented choice about combining CLA and L-carnitine
Cancer cells not only switch from OXPHOS to lactate-dependent energy-generating pathways, but also upregulate antioxidant-related genes [e.g., NF-E2-related factor 2 (Nrf2)] to overcome a wide range of oxidative stress [27]
Use of continuous glucose monitors (CGMs): Many patients on GLP-1 therapies also use continuous glucose monitors (CGMs)